Skip to main content
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. — Investor Relations & Filings

Ticker · BCAX ISIN · US0554771032 US Manufacturing
Filings indexed 168 across all filing types
Latest filing 2026-05-11 Interim / Quarterly Rep…
Country US United States of America
Listing US BCAX

About Bicara Therapeutics Inc.

https://www.bicara.com/

Bicara Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class, dual-action biologics for cancer treatment. The company engineers bifunctional therapies that combine the precision of targeted treatments with the activation of a potent and durable anti-tumor immune response. This approach is designed to deliver therapeutic impact directly within the tumor microenvironment, with a primary focus on developing treatments for patients with solid tumors.

Recent filings

Filing Released Lang Actions
10-Q - Bicara Therapeutics Inc. (0002023658) (Filer)
Interim / Quarterly Report
2026-05-11 English
8-K - Bicara Therapeutics Inc. (0002023658) (Filer)
Regulatory Filings
2026-05-11 English
ARS - Bicara Therapeutics Inc. (0002023658) (Filer)
Annual Report
2026-04-27 English
DEF 14A - Bicara Therapeutics Inc. (0002023658) (Filer)
Proxy Solicitation & Information Statement
2026-04-27 English
8-K - Bicara Therapeutics Inc. (0002023658) (Filer)
Regulatory Filings
2026-03-30 English
4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
Director's Dealing
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.